2025 was a year of solid progress and meaningful milestones for Saikang Medical. Throughout the year, the company continued to advance across multiple dimensions—including intelligent manufacturing, brand development, technological innovation, and industry–academia–research integration—earning a series of provincial, industry-level, and national honors.
I. Craftsmanship in Manufacturing Recognized by Authorities: Provincial Honors Including the Jiangsu May 1st Labor Award
According to the Decision on Commending the 2025 Jiangsu May 1st Labor Award, Jiangsu Worker Pioneer, and Jiangsu May 1st Women Role Model, the Final Assembly Production Line of Jiangsu Saikang Medical Equipment Co., Ltd. was officially recognized.
In daily operations, the final assembly line consistently faces challenges such as tight delivery schedules, complex processes, and high quality requirements. Guided by production planning, the team strictly follows established process flows, exercising step-by-step control over critical stages including assembly precision, installation of key components, and functional testing—ensuring all products meet relevant standards before delivery.
To address structural and process differences among various models and batches, the assembly line adjusts assembly sequences and operating methods in a timely manner based on specific technical requirements, ensuring smooth coordination and stable operations.

II. Continuous Growth in Brand Value: Recognized as a “Jiangsu Province Well-Known Trademark”
The title “Jiangsu Province Well-Known Trademark” is awarded to trademarks with a solid market presence and recognition within the province. The evaluation process is relatively rigorous, covering factors such as duration of trademark use, market coverage, industry application, consumer awareness, as well as standardized use and protection of the trademark.
Saikang Medical’s recognition as a Jiangsu Province Well-Known Trademark is a result of comprehensive assessment based on the company’s actual operations in the medical equipment sector, product application scope, and brand usage.

III. Innovation Capabilities Reaffirmed: Successfully Passing High-Tech Enterprise Re-evaluation
In the Announcement on the Re-evaluation of the First Batch of High-Tech Enterprises Recognized and Filed in 2025, Saikang Medical successfully passed the high-tech enterprise re-evaluation.
As a company continuously engaged in R&D and the commercialization of technological achievements in the medical equipment field, Saikang Medical operates based on independently owned intellectual property. Over the past year, the company has maintained stable investment in R&D, core technology development, and application of results—providing strong technical support for product upgrades and innovation.
With its high-tech enterprise qualification, Saikang Medical is better positioned to participate in government projects and funding programs, while also gaining additional opportunities in market expansion and brand development.

IV. Industry Reputation Demonstrated: HCMA Outstanding Supplier Award
In the 2025 HCMA Awards, Saikang Medical was honored with the title of “Outstanding Hospital Decoration Materials Supplier of 2024.”
This award, selected by an authoritative industry organization, focuses on comprehensive performance in areas such as product quality, project delivery capability, service standards, and industry reputation. Through its strong performance in hospital construction and medical space solutions, Saikang Medical earned high recognition from both the industry and its clients.

V. A High-Growth Enterprise Representative: Selected for the Suzhou Gazelle Enterprise Program
Saikang Medical was successfully included in the 2024 Suzhou Gazelle Enterprise Program.

“Gazelle enterprises” refer to small and medium-sized companies that achieve rapid growth within a short period, typically driven by technological innovation or distinctive business models, and demonstrate strong growth potential and market competitiveness.
Saikang Medical’s inclusion in the 2024 Suzhou Gazelle Program indicates that the company has maintained strong growth momentum within its specialized medical equipment segment and possesses solid market expansion capabilities. Following its selection, the company can benefit from enhanced policy support, resource access, and business development opportunities.
VI. Outstanding Industry–Academia–Research Integration: China Industry–University–Research Cooperation Association Science & Technology Innovation Award
In the 2024 Science & Technology Innovation Awards organized by the China Industry–University–Research Cooperation Association, Saikang Medical received the Innovation Achievement Award.
This award recognizes enterprises that have made tangible progress in the transformation of scientific and technological achievements and in industry–academia–research collaboration. Saikang Medical has long maintained close cooperation with universities and research institutions, effectively applying research outcomes to product development and real-world applications—ensuring that technology truly delivers value.

From provincial recognition of the final assembly line, to brand acknowledgment as a well-known trademark, successful high-tech enterprise re-evaluation, selection as a Gazelle enterprise, and awards for industry–academia–research innovation—
These honors collectively reflect Saikang Medical’s comprehensive strengths in manufacturing, technology, branding, and innovation. They also lay a solid foundation for future technological applications, market expansion, and industrial upgrading.
The achievements of 2025 are not only an affirmation, but also a new starting point. Driven by continuous innovation, Saikang Medical will move forward with steady and sustainable growth.
Post time: Dec-29-2025



